PERIPROCEDURAL DABIGATRAN IN PATIENTS UNDERGOING CATHETER ABLATION FOR ATRIAL FIBRILLATION

被引:2
作者
Khan, Saadat [1 ]
Duggal, Manoj [1 ]
Dunskis, Paula [1 ]
Bhan, Adarsh [1 ]
机构
[1] Christ Med Ctr, Oak Lawn, IL USA
关键词
D O I
10.1016/S0735-1097(13)60401-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E401 / E401
页数:1
相关论文
共 50 条
[21]   Case Report: Catheter Ablation of Atrial Fibrillation in Patients with Dabigatran [J].
Stix, G. .
JOURNAL FUR KARDIOLOGIE, 2014, 21 (3-4) :92-94
[22]   Periprocedural anticoagulation in patients undergoing cryoballoon ablation for atrial fibrillation [J].
Dilaveris, Polychronis ;
Tousoulis, Dimitris .
HELLENIC JOURNAL OF CARDIOLOGY, 2016, 57 (05) :338-339
[23]   Meta-analysis of dabigatran vs warfarin in patients undergoing catheter ablation for atrial fibrillation [J].
Phan, Kevin ;
Wang, Nelson ;
Pison, Laurent ;
Kumar, Narendra ;
Hitos, Kerry ;
Thomas, Stuart P. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 189 :199-203
[24]   Periprocedural Dabigatran in Atrial Fibrillation Ablation: A New Kid on the Block [J].
Pelargonio, Gemma ;
Perna, Francesco .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2013, 24 (08) :866-868
[25]   Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation [J].
Rillig, Andreas ;
Lin, Tina ;
Plesman, Joaquina ;
Heeger, Christian-H. ;
Lemes, Christine ;
Metzner, Andreas ;
Mathew, Shibu ;
Wissner, Erik ;
Wohlmuth, Peter ;
Ouyang, Feifan ;
Kuck, Karl-Heinz ;
Tilz, Roland Richard .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2016, 27 (02) :147-153
[26]   Can Dabigatran Be an Alternative Periprocedural Anticoagulation for Atrial Fibrillation Ablation? [J].
Takahashi, Naohiko .
CIRCULATION JOURNAL, 2012, 76 (10) :2327-2328
[27]   Discontinuation period and periprocedural events of novel oral anticoagulation in patients undergoing catheter ablation of atrial fibrillation [J].
Hirose, S. ;
Miyamoto, K. ;
Nakajima, I. ;
Ishibashi, K. ;
Okamura, H. ;
Noda, T. ;
Aiba, T. ;
Kamakura, S. ;
Kusano, K. .
EUROPEAN HEART JOURNAL, 2014, 35 :390-390
[28]   Periprocedural complication rates in respect of anticoagulation strategies in patients undergoing catheter ablation for persistent atrial fibrillation [J].
Gunawardene, M. ;
Steven, D. ;
Sultan, A. ;
Schaeffer, B. ;
Schreiber, D. ;
Moser, J. ;
Akbulak, R. Oe ;
Servatius, H. ;
Hoffmann, B. A. ;
Willems, S. .
EUROPEAN HEART JOURNAL, 2015, 36 :567-567
[29]   Evaluation of Periprocedural Safety and Efficacy of Dabigatran, Rivaroxaban, Apixaban and Edoxaban During Catheter Ablation for Atrial Fibrillation [J].
Tohoku, Shota ;
Hiroshima, Kenichi ;
Nagashima, Michio ;
Morita, Junji ;
Iseda, Takahiro ;
Ando, Kengo ;
Ando, Kenji .
CIRCULATION, 2016, 134
[30]   Rivaroxaban versus warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation: A meta-analysis [J].
Phan, Kevin ;
Wang, Nelson ;
Pison, Laurent ;
Kumar, Narendra ;
Hitos, Kerry ;
Thomas, Stuart P. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 185 :209-213